We found no differences in circulating tumour cells when control MCF7 or MAF-positive MCF7 cells were implanted into mammary fat pads, suggesting that MAF supports late events in the metastatic cascade (Extended Data Fig. 1b). This evidence concerns the gene MAF and neoplasm.